PMID- 7526306 OWN - NLM STAT- MEDLINE DCOM- 19941213 LR - 20091026 IS - 0029-7844 (Print) IS - 0029-7844 (Linking) VI - 84 IP - 6 DP - 1994 Dec TI - Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? PG - 937-40 AB - OBJECTIVE: To determine if plasma concentrations of defined cytokines are increased in women with preeclampsia, and to correlate any increases with the elevated concentrations of the vascular cell adhesion molecule (VCAM)-1. METHODS: Twenty primigravidas with preeclampsia were compared to 20 healthy primigravidas. Plasma levels of cytokines, tumor necrosis factor-alpha (TNF alpha), interleukin (IL)-6, IL-8, IL-1 beta, IL-1 receptor antagonist (IL-1ra), granulocyte macrophage-colony-stimulating factor (GM-CSF), and VCAM-1, were measured by enzyme-linked immunosorbent assay. RESULTS: Concentrations of IL-6 and IL-1ra were significantly higher (P < .01) in preeclamptic women (2.56 and 251.85 pg/mL, respectively) compared to normal pregnant patients (2.06 and 142.00 pg/mL, respectively). There were no significant changes in concentrations of TNF alpha, IL-8, GM-CSF, and IL-1 beta in preeclamptic patients (14.09, 50.52, 125.8, and 2.08 pg/mL, respectively) compared to normal patients (11.96 44.46, 121.3, and 2.01 pg/mL, respectively). Serum concentrations of VCAM-1 were increased in women with preeclampsia (preeclamptic group 841.9 +/- 49.7 ng/mL, control group 560.2 +/- 47.9 ng/mL; t = 3.673, P < .001). Interleukin-6 and IL-1ra concentrations correlated with VCAM-1 concentrations (IL-6: r = 0.539, z = 2.9, P < .005; IL-1ra: r = 0.451, z = 2.428, P < .02). CONCLUSIONS: Increased cytokine concentrations may contribute to the endothelial damage that occurs with preeclampsia and may explain the mechanism underlying leukocyte activation in this disorder. The increased cytokine concentration may also be responsible for the endothelial adhesion that accompanies preeclampsia. FAU - Greer, I A AU - Greer IA AD - Department of Obstetrics and Gynecology, Royal Infirmary, Glasgow, Scotland, United Kingdom. FAU - Lyall, F AU - Lyall F FAU - Perera, T AU - Perera T FAU - Boswell, F AU - Boswell F FAU - Macara, L M AU - Macara LM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Obstet Gynecol JT - Obstetrics and gynecology JID - 0401101 RN - 0 (Cell Adhesion Molecules) RN - 0 (Interleukin-1) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (Receptors, Interleukin-1) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) SB - IM MH - Adult MH - Cell Adhesion Molecules/blood MH - Endothelium, Vascular/*physiopathology MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Granulocyte-Macrophage Colony-Stimulating Factor/blood MH - Humans MH - Interleukin-1/blood MH - Interleukin-6/*blood MH - Interleukin-8/blood MH - Pre-Eclampsia/*blood/physiopathology MH - Pregnancy MH - Receptors, Interleukin-1/*antagonists & inhibitors MH - Tumor Necrosis Factor-alpha/analysis MH - Vascular Cell Adhesion Molecule-1 EDAT- 1994/12/01 00:00 MHDA- 1994/12/01 00:01 CRDT- 1994/12/01 00:00 PHST- 1994/12/01 00:00 [pubmed] PHST- 1994/12/01 00:01 [medline] PHST- 1994/12/01 00:00 [entrez] PST - ppublish SO - Obstet Gynecol. 1994 Dec;84(6):937-40.